
Testimony: High Drug Prices Have ‘Enormous Human Cost’
Executives from Valeant Pharmaceuticals testified before a Senate committee Wednesday regarding the company’s pricing practices. A U-M physician told his patients’ side of the story.
April 27, 2016 4:00 PM